NCT03185208View on ClinicalTrials.gov

Lithium As a Treatment to Prevent Impairment of Cognition in Elders

PHASE4CompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

February 2, 2018

Primary Completion Date

August 6, 2024

Study Completion Date

August 6, 2024

Conditions
Mild Cognitive Impairment
Interventions
DRUG

Lithium Carbonate

See lithium carbonate arm

DRUG

Placebo oral capsule

See placebo arm

Trial Locations (1)

15213

University of Pittsburgh Medical Center, Pittsburgh

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

Ariel Gildengers, MD

OTHER

NCT03185208 - Lithium As a Treatment to Prevent Impairment of Cognition in Elders | Biotech Hunter | Biotech Hunter